Latest News about GSK
Recent news which mentions GSK
From Benzinga
Verona Pharma's Promising COPD Treatment Puts It in GSK's Acquisition Crosshairs, Analysts Predict Big Moves
December 29, 2023
From Benzinga
Expensive Drugs For Americans In 2024? Drugmakers Including Pfizer, Sanofi Mull Price Increase In January
December 29, 2023
From Benzinga
Pharmaceutical Giants Brace for Showdown as Medicare Drug Price Negotiations Are Poised For 2024
December 28, 2023
From Benzinga
3 Growth at a Reasonable Price (GARP) Stocks for Balanced Growth
December 22, 2023
From InvestorPlace
From Benzinga
COVAX Global Initiative For COVID-19 Vaccines Comes To An End Amid Shift To Regular Programs
December 20, 2023
From Benzinga
GSK's Jemperli Cancer Drug Hits Primary Goal In Endometrial Cancer Study
December 18, 2023
Tickers
GSK
From Benzinga
3 Machine Learning Stocks to Turn $10,000 Into $1 Million: December 2023
December 14, 2023
From InvestorPlace
From Benzinga
Competition and Optimism: GSK's CEO Walmsley Foresees Growth Despite Competition In RSV Vaccine Market
November 30, 2023
Tickers
GSK
From Benzinga
3 Stocks to Sell for Tax Losses Before the New Year
November 28, 2023
From InvestorPlace
3 Great Foreign Companies to Invest in Right Now
November 27, 2023
From Motley Fool
GSK Frames A Comeback For Its Multiple Myeloma Drug Following Encouraging Phase 3 Data
November 27, 2023
Tickers
GSK
From Benzinga
Merck's Latest Drug For Chronic Cough Faces FDA Pushback
November 18, 2023
From Benzinga
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
November 17, 2023
From Benzinga
From Benzinga
From Benzinga
6 Nasdaq 100 Stocks Down 40% or More that Will Soar As Much 367%
November 08, 2023
From InvestorPlace
3 Healthcare Stocks Getting Help From the Aging Population
November 06, 2023
From InvestorPlace
3 Top Dividend Stock Picks for Steady Income and Capital Appreciation
November 02, 2023
From InvestorPlace
Moderna posts wider-than-expected loss, reins in full-year outlook
November 02, 2023
From MarketWatch
GSK Lifts Annual Guidance Again Helped By Strong Launch Of RSV Vaccine, Steady Demand For Shingles Shot
November 01, 2023
Tickers
GSK
From Benzinga
Nasdaq, S&P 500 Futures Slide Ahead Of Fed Decision, Economic Data: Analyst Tells Why November Could Herald 'Good News'
November 01, 2023
From Benzinga
Johnson & Johnson Offloads Rights For Hepatitis B Candidate To GSK
October 31, 2023
From Benzinga
Hope for Endometrial Cancer - GSK Drug Proves Effective in Increasing Survival Rates
October 30, 2023
Tickers
GSK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.